Karen FERRANTE;TOKAI PHARMACEUTICALS, INC.;Eva COREY;University of Washington;Vincent NJAR;University of Maryland, Baltimore;Amina ZOUBEIDI
发明人:
Vincent C.O. Njar,Amina Zoubeidi,Karen Ferrante,Eva Corey,Dr. Douglas Jacoby
申请号：
US14758938
公开号：
US20160038511A1
申请日:
2014.08.12
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Described herein are methods and compositions for the treatment of prostate cancer in a subject in need thereof. The prostate cancer may be a castration resistant and an androgen receptor antagonist-resistant prostate cancer. The methods may comprise administering to the subject a CYP17-lyase inhibitor of Formula II.
